Find clinical trials for Triple Negative Breast Cancer in Atlanta, GA

Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatment naive ...

or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in patients with non-surgically removable locally advanced or metastatic triple...

This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...

doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...

This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...

with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...